ecrin-mdr-crcClinical2022Colorectal NeoplasmsAdvanced Colorectal CancerColorectal NeoplasmsAdvanced Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/22193299CetuximabBevacizumabECRIN MDRNot yet recruitingfalseLEAC-102 for Advanced Colorectal CancerA Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of LEAC-102 in Combination with FOLFOX + Bevacizumab/Cetuximab in Subjects with Advanced Colorectal Cancer2022-09-152219329NCT02826837